Furthermore, we have found that complement activation promotes KSHV persistent latent infection by activating the NF-κB pathway, which enhances the survival of KSHV-infected cells and inhibits viral lytic replication. This evidence concerns the gene NFKB1 and disease arising from reactivation of latent virus.